Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel
There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC. A computeris...
Saved in:
Published in | European urology Vol. 70; no. 6; pp. 1052 - 1068 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Elsevier B.V
01.12.2016
|
Subjects | |
Online Access | Get full text |
ISSN | 0302-2838 1873-7560 1873-7560 |
DOI | 10.1016/j.eururo.2016.07.014 |
Cover
Abstract | There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC).
To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC.
A computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point.
Seven studies compared KSS overall (n=547) versus RNU (n=1376). Information on the comparison of SU (n=586) versus RNU (n=3692), URS (n=162) versus RNU (n=367), and PC (n=66) versus RNU (n=114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS.
Our systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias.
We reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours.
The use of endoscopic surgery for upper tract urothelial carcinoma should be restrained to patients with favourable tumours. Indications for segmental ureterectomy could be extended to selected individuals with more aggressive disease. These findings are limited by a selection bias. |
---|---|
AbstractList | There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC).CONTEXTThere is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC).To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC.OBJECTIVETo systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC.A computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point.EVIDENCE ACQUISITIONA computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point.Seven studies compared KSS overall (n=547) versus RNU (n=1376). Information on the comparison of SU (n=586) versus RNU (n=3692), URS (n=162) versus RNU (n=367), and PC (n=66) versus RNU (n=114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS.EVIDENCE SYNTHESISSeven studies compared KSS overall (n=547) versus RNU (n=1376). Information on the comparison of SU (n=586) versus RNU (n=3692), URS (n=162) versus RNU (n=367), and PC (n=66) versus RNU (n=114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS.Our systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias.CONCLUSIONSOur systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias.We reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours.PATIENT SUMMARYWe reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours. Abstract Context There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). Objective To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC. Evidence acquisition A computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point. Evidence synthesis Seven studies compared KSS overall ( n = 547) versus RNU ( n = 1376). Information on the comparison of SU ( n = 586) versus RNU ( n = 3692), URS ( n = 162) versus RNU ( n = 367), and PC ( n = 66) versus RNU ( n = 114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS. Conclusions Our systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias. Patient summary We reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours. There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC. A computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point. Seven studies compared KSS overall (n=547) versus RNU (n=1376). Information on the comparison of SU (n=586) versus RNU (n=3692), URS (n=162) versus RNU (n=367), and PC (n=66) versus RNU (n=114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS. Our systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias. We reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours. There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC). To systematically review the current literature comparing oncologic outcomes of KSS versus RNU for UTUC. A computerised bibliographic search of the Medline, Embase, and Cochrane databases was performed for all studies reporting comparative oncologic outcomes of KSS versus RNU. Approaches considered for KSS were segmental ureterectomy (SU) and ureteroscopic (URS) or percutaneous (PC) management. Using the methodology recommended by the Preferred Reporting Items for Systematic Reviews and Meta-analysis guidelines, we identified 22 nonrandomised comparative retrospective studies published between 1999 and 2015 that were eligible for inclusion in this systematic review. A narrative review and risk-of-bias (RoB) assessment were performed using cancer-specific survival (CSS) as the primary end point. Seven studies compared KSS overall (n=547) versus RNU (n=1376). Information on the comparison of SU (n=586) versus RNU (n=3692), URS (n=162) versus RNU (n=367), and PC (n=66) versus RNU (n=114) was available in 10, 5, and 2 studies, respectively. No significant difference was found between SU and RNU in terms of CSS or any other oncologic outcomes. Only patients with low-grade and noninvasive tumours experienced similar CSS after URS or PC when compared with RNU, despite an increased risk of local recurrence following endoscopic management of UTUC. The RoB assessment revealed, however, that the analyses were subject to a selection bias favouring KSS. Our systematic review suggests similar survival after KSS versus RNU only for low-grade and noninvasive UTUC when using URS or PC. However, selected patients with high-grade and invasive UTUC could safely benefit from SU when feasible. These results should be interpreted with caution due to the risk of selection bias. We reviewed the studies that compared kidney-sparing surgery versus radical nephroureterectomy for upper tract urothelial carcinoma. We found similar oncologic outcomes for favourable tumours when using ureteroscopic or percutaneous management, whereas indications for segmental ureterectomy could be extended to selected cases of aggressive tumours. The use of endoscopic surgery for upper tract urothelial carcinoma should be restrained to patients with favourable tumours. Indications for segmental ureterectomy could be extended to selected individuals with more aggressive disease. These findings are limited by a selection bias. |
Author | Dominguez-Escrig, Jose Luis Zigeuner, Richard van Rhijn, Bas W.G. Böhle, Andreas Compérat, Eva M. Yuan, Cathy Yuhong Rouprêt, Morgan Palou, Joan Kaasinen, Eero Seisen, Thomas Cowan, Nigel C. Peyronnet, Benoit Bruins, Harman M. Sylvester, Richard J. Babjuk, Marko Burger, Maximilian Shariat, Shahrokh F. |
Author_xml | – sequence: 1 givenname: Thomas surname: Seisen fullname: Seisen, Thomas email: thomas.seisen@gmail.com organization: Academic Department of Urology, Pitié-Salpétrière Hospital, Assistance-Publique Hôpitaux de Paris; Pierre et Marie Curie Medical School, University Paris 6, Paris, France – sequence: 2 givenname: Benoit surname: Peyronnet fullname: Peyronnet, Benoit organization: Department of Urology, University of Rennes, Rennes, France – sequence: 3 givenname: Jose Luis surname: Dominguez-Escrig fullname: Dominguez-Escrig, Jose Luis organization: Department of Urology, Fundación Instituto Valenciano de Oncología, Valencia, Spain – sequence: 4 givenname: Harman M. surname: Bruins fullname: Bruins, Harman M. organization: Department of Urology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands – sequence: 5 givenname: Cathy Yuhong surname: Yuan fullname: Yuan, Cathy Yuhong organization: Department of Medicine, Division of Gastroenterology, McMaster University, Hamilton, ON, Canada – sequence: 6 givenname: Marko surname: Babjuk fullname: Babjuk, Marko organization: Department of Urology, Hospital Motol, Second Faculty of Medicine, Charles University, Praha, Czech Republic – sequence: 7 givenname: Andreas surname: Böhle fullname: Böhle, Andreas organization: Department of Urology, HELIOS Agnes-Karll-Krankenhaus, Bad Schwartau, Germany – sequence: 8 givenname: Maximilian surname: Burger fullname: Burger, Maximilian organization: Department of Urology, Caritas St. Josef Medical Centre, University of Regensburg, Regensburg, Germany – sequence: 9 givenname: Eva M. surname: Compérat fullname: Compérat, Eva M. organization: Department of Pathology, Hôpital La Pitié-Salpétrière, UPMC, Paris, France – sequence: 10 givenname: Nigel C. surname: Cowan fullname: Cowan, Nigel C. organization: Radiology Department, Queen Alexandra Hospital, Portsmouth, UK – sequence: 11 givenname: Eero surname: Kaasinen fullname: Kaasinen, Eero organization: Department of Urology, Hyvinkää Hospital, Hyvinkää, Finland – sequence: 12 givenname: Joan surname: Palou fullname: Palou, Joan organization: Department of Urology, Fundació Puigvert, Universidad Autónoma de Barcelona, Barcelona, Spain – sequence: 13 givenname: Bas W.G. surname: van Rhijn fullname: van Rhijn, Bas W.G. organization: Department of Surgical Oncology (Urology), Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands – sequence: 14 givenname: Richard J. surname: Sylvester fullname: Sylvester, Richard J. organization: European Association of Urology Guidelines Office, Brussels, Belgium – sequence: 15 givenname: Richard surname: Zigeuner fullname: Zigeuner, Richard organization: Department of Urology, Medical University of Graz, Graz, Austria – sequence: 16 givenname: Shahrokh F. surname: Shariat fullname: Shariat, Shahrokh F. organization: Department of Urology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria – sequence: 17 givenname: Morgan surname: Rouprêt fullname: Rouprêt, Morgan organization: Academic Department of Urology, Pitié-Salpétrière Hospital, Assistance-Publique Hôpitaux de Paris; Pierre et Marie Curie Medical School, University Paris 6, Paris, France |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27477528$$D View this record in MEDLINE/PubMed |
BookMark | eNqVUl1r2zAUNaNjTbv9gzH0uBdnkr_klDHIQtuVlWY0zV6FIl2nymzJlewM_8L-rV2T9mUwykBwEZxz7uWccxIdWWchit4zOmWUFZ92U-h97900wd-U8ill2atowkqexjwv6FE0oSlN4qRMy-PoJIQdpTTNZ-mb6DjhGed5Uk6ix6VVrnZbo8iy75RrIBBXke9GWxji0Epv7Jaser8FP5Cf4EMfyK3URsma3EB7713voQMPqnPNQCrnybptwZM7L1VH1t5191AbRC-kV8a6Rp6ROVkNoYNGdrj3FvYGfpPNQBBJzudrcuNs3PRB1UCu7F4GswfytZZao-xCWoXjsjcaZS2e-0NaqN9GrytZB3j3NE-j9cX53eJbfL28vFrMr2OVp0UX55zqBPJS8TQpy7SqFKtozjmrmMwryTY6YTTVFRpU6hmt8ozqTEFRZlmh8KWn0ceDbuvdQw-hE40JCuoaj3B9EKxMCp6h0wVCPzxB-00DWrTeNNIP4tl8BJwdAMq7EDxUQpkOLXG289LUglExJi124pC0GJMWlAtMGsnZX-Rn_RdoXw40QJPQdy-CMoCWajNGKLQz_yugMIaxDr9ggLDDOlgMQDAREkHFauzgWEFWpDRjsxwFPv9b4OX9fwB5VvG1 |
CitedBy_id | crossref_primary_10_3390_cancers16223795 crossref_primary_10_3389_fonc_2023_944321 crossref_primary_10_3389_fonc_2024_1426003 crossref_primary_10_1097_MOU_0000000000000598 crossref_primary_10_4103_UROS_UROS_49_20 crossref_primary_10_1002_cncr_30516 crossref_primary_10_1093_jjco_hyad152 crossref_primary_10_1016_j_eururo_2016_09_028 crossref_primary_10_1007_s00345_023_04689_1 crossref_primary_10_1016_j_eururo_2016_09_027 crossref_primary_10_1002_bco2_502 crossref_primary_10_3390_cancers15184585 crossref_primary_10_1080_21681805_2022_2107065 crossref_primary_10_1016_j_canlet_2021_02_010 crossref_primary_10_1002_tre_947 crossref_primary_10_1016_j_urology_2021_06_053 crossref_primary_10_1007_s00761_022_01220_w crossref_primary_10_3390_ijms23052602 crossref_primary_10_1080_14737140_2019_1698295 crossref_primary_10_1111_iju_14336 crossref_primary_10_1177_11795549221147993 crossref_primary_10_3389_fonc_2022_825476 crossref_primary_10_1080_2090598X_2021_1883810 crossref_primary_10_1007_s00345_022_04156_3 crossref_primary_10_1007_s00761_024_01626_8 crossref_primary_10_1016_j_urolonc_2024_04_021 crossref_primary_10_23736_S2724_6051_23_05593_3 crossref_primary_10_3389_fonc_2022_858813 crossref_primary_10_3390_cancers16223772 crossref_primary_10_1007_s00432_023_05207_x crossref_primary_10_3390_pr9122136 crossref_primary_10_1007_s00120_020_01323_5 crossref_primary_10_1016_j_urolonc_2020_08_004 crossref_primary_10_2147_CMAR_S259964 crossref_primary_10_3389_fonc_2022_872432 crossref_primary_10_1016_j_ijbiomac_2024_135608 crossref_primary_10_1016_j_urolonc_2023_09_019 crossref_primary_10_1016_j_conctc_2018_01_007 crossref_primary_10_1007_s00345_019_02811_w crossref_primary_10_1111_ctr_13559 crossref_primary_10_1007_s00345_018_2506_1 crossref_primary_10_1016_j_euros_2022_04_007 crossref_primary_10_1016_j_clgc_2023_11_015 crossref_primary_10_1186_s12885_024_12913_3 crossref_primary_10_4103_UROS_UROS_54_22 crossref_primary_10_1177_2050313X231176356 crossref_primary_10_3390_cancers15184495 crossref_primary_10_3390_jcm11195815 crossref_primary_10_1016_j_humpath_2022_03_004 crossref_primary_10_1111_bju_15494 crossref_primary_10_3390_jcm13216593 crossref_primary_10_1186_s12894_023_01265_y crossref_primary_10_1245_s10434_024_16757_w crossref_primary_10_3389_fonc_2022_769252 crossref_primary_10_1097_CU9_0000000000000164 crossref_primary_10_1007_s00432_023_05264_2 crossref_primary_10_1148_rg_240056 crossref_primary_10_3390_biomedicines11071775 crossref_primary_10_1016_j_eururo_2021_05_004 crossref_primary_10_3390_cancers15061874 crossref_primary_10_3389_fonc_2023_1225428 crossref_primary_10_1177_1758835920937950 crossref_primary_10_1016_j_urolonc_2019_02_004 crossref_primary_10_1016_j_urolonc_2020_03_005 crossref_primary_10_1097_CU9_0000000000000158 crossref_primary_10_1016_j_urolonc_2022_02_016 crossref_primary_10_1016_j_euros_2021_08_003 crossref_primary_10_3390_cancers15205020 crossref_primary_10_1016_j_asjsur_2022_04_077 crossref_primary_10_1080_21681805_2022_2091018 crossref_primary_10_1007_s00345_019_02790_y crossref_primary_10_1186_s12894_024_01439_2 crossref_primary_10_1007_s11255_020_02439_5 crossref_primary_10_12998_wjcc_v9_i8_1916 crossref_primary_10_1016_j_euros_2021_08_002 crossref_primary_10_1038_s41598_021_83495_4 crossref_primary_10_3389_fonc_2024_1419882 crossref_primary_10_1080_14737140_2019_1621753 crossref_primary_10_1089_end_2019_0725 crossref_primary_10_1016_j_eururo_2020_05_042 crossref_primary_10_1016_j_urology_2018_10_004 crossref_primary_10_1016_j_heliyon_2023_e22408 crossref_primary_10_1016_j_urolonc_2023_08_013 crossref_primary_10_3390_curroncol29120727 crossref_primary_10_1016_j_urolonc_2024_05_019 crossref_primary_10_1016_j_purol_2019_01_005 crossref_primary_10_1007_s00345_023_04693_5 crossref_primary_10_1111_iju_13826 crossref_primary_10_1111_iju_15208 crossref_primary_10_1007_s11912_023_01460_y crossref_primary_10_1093_jscr_rjab544 crossref_primary_10_1136_esmoopen_2016_000126 crossref_primary_10_1016_j_ajur_2024_08_003 crossref_primary_10_1186_s12894_020_00744_w crossref_primary_10_1097_MD_0000000000022176 crossref_primary_10_1007_s00345_020_03124_z crossref_primary_10_1002_btm2_10353 crossref_primary_10_1016_j_hoc_2021_02_005 crossref_primary_10_5301_tj_5000705 crossref_primary_10_1016_j_asjsur_2025_01_004 crossref_primary_10_3390_ijms20133162 crossref_primary_10_1016_j_acuroe_2018_07_002 crossref_primary_10_1016_j_purol_2022_08_003 crossref_primary_10_1007_s00261_019_02293_9 crossref_primary_10_1016_j_urology_2019_10_005 crossref_primary_10_1016_j_clgc_2018_01_015 crossref_primary_10_1016_j_eururo_2023_03_013 crossref_primary_10_3390_uro2010003 crossref_primary_10_1016_j_urolonc_2023_04_010 crossref_primary_10_1002_cam4_5544 crossref_primary_10_1016_j_acuro_2018_01_010 crossref_primary_10_1007_s11912_021_01179_8 crossref_primary_10_1016_j_urolonc_2022_11_020 crossref_primary_10_1016_j_euf_2025_01_009 crossref_primary_10_1016_j_pdpdt_2020_102067 crossref_primary_10_1089_end_2024_0061 crossref_primary_10_1111_iju_13522 crossref_primary_10_1200_EDBK_237451 crossref_primary_10_1177_1179554920927662 crossref_primary_10_1016_j_humpath_2021_09_007 crossref_primary_10_3390_jpm13040591 crossref_primary_10_1080_21681805_2021_1916073 crossref_primary_10_3390_cancers14163962 crossref_primary_10_1177_03008916231186178 crossref_primary_10_1200_JCO_2016_69_4141 crossref_primary_10_1016_j_euf_2023_05_012 crossref_primary_10_3390_jcm12154907 crossref_primary_10_1016_j_conctc_2022_100902 crossref_primary_10_3390_cancers16010044 crossref_primary_10_1016_S1636_5577_22_46926_4 crossref_primary_10_1007_s13691_020_00402_w crossref_primary_10_1038_nrurol_2017_203 crossref_primary_10_1111_bju_15925 crossref_primary_10_1016_j_urology_2021_03_003 crossref_primary_10_3390_ijms23116305 crossref_primary_10_3389_fonc_2023_1143030 crossref_primary_10_1186_s12894_023_01387_3 crossref_primary_10_1016_j_urology_2020_09_036 crossref_primary_10_1016_j_fjurol_2024_102722 crossref_primary_10_1038_s41598_021_87573_5 crossref_primary_10_1007_s00345_024_05032_y crossref_primary_10_1093_jjco_hyaa132 crossref_primary_10_3389_fonc_2022_889028 crossref_primary_10_3390_pharmaceutics16081067 crossref_primary_10_1097_MOU_0000000000001078 crossref_primary_10_3233_BLC_220093 crossref_primary_10_1089_end_2021_0133 crossref_primary_10_1007_s00345_024_05222_8 crossref_primary_10_3389_fonc_2022_907975 crossref_primary_10_1016_j_eururo_2025_02_023 crossref_primary_10_1016_S1166_7087_20_30750_8 crossref_primary_10_1245_s10434_021_10233_5 crossref_primary_10_1186_s12894_024_01629_y crossref_primary_10_3389_fonc_2024_1406031 crossref_primary_10_1002_lsm_23079 crossref_primary_10_1016_j_euo_2021_09_002 crossref_primary_10_1016_j_urology_2020_06_083 crossref_primary_10_1097_MOU_0000000000001248 crossref_primary_10_1007_s00345_019_02682_1 crossref_primary_10_1007_s00345_023_04687_3 crossref_primary_10_4103_iju_IJU_93_20 crossref_primary_10_1097_MOU_0000000000001240 crossref_primary_10_1245_s10434_024_16523_y crossref_primary_10_1097_MOU_0000000000001120 crossref_primary_10_1007_s00345_019_02739_1 crossref_primary_10_1007_s00120_024_02422_3 crossref_primary_10_1016_j_clgc_2019_10_015 crossref_primary_10_1016_j_eucr_2021_101944 crossref_primary_10_1186_s12906_020_2861_5 crossref_primary_10_1007_s40336_020_00378_w crossref_primary_10_1016_j_ucl_2020_09_011 crossref_primary_10_1111_bju_14697 crossref_primary_10_1016_j_clgc_2020_09_002 crossref_primary_10_1016_j_urolonc_2022_10_029 crossref_primary_10_1002_iju5_12534 crossref_primary_10_1016_j_juro_2017_07_088 crossref_primary_10_1007_s11255_019_02230_1 crossref_primary_10_1089_end_2023_0092 crossref_primary_10_3390_jcm11051307 crossref_primary_10_1111_ases_13216 crossref_primary_10_23736_S2724_6051_24_05737_9 crossref_primary_10_1186_s12957_021_02297_0 crossref_primary_10_3390_cancers15215122 crossref_primary_10_1007_s11255_023_03838_0 crossref_primary_10_23736_S2724_6051_23_05354_5 crossref_primary_10_1080_14737140_2018_1481395 crossref_primary_10_2196_15363 crossref_primary_10_1016_j_euros_2024_06_005 crossref_primary_10_1016_j_purol_2018_07_284 crossref_primary_10_1089_end_2024_0654 crossref_primary_10_1186_s12894_019_0557_2 crossref_primary_10_1016_j_urolonc_2017_05_009 crossref_primary_10_1080_21681805_2022_2041086 crossref_primary_10_1016_j_urolonc_2024_03_012 crossref_primary_10_3389_fruro_2022_903693 crossref_primary_10_24060_2076_3093_2021_11_4_323_327 crossref_primary_10_1007_s00262_020_02827_x crossref_primary_10_1016_j_fpurol_2024_07_206 crossref_primary_10_1007_s00120_024_02421_4 crossref_primary_10_1016_j_eururo_2017_07_036 crossref_primary_10_1111_bju_15566 crossref_primary_10_1016_S1761_3310_22_46063_4 crossref_primary_10_1155_2018_2793172 crossref_primary_10_1038_s41598_024_77117_y crossref_primary_10_1007_s00345_019_02646_5 crossref_primary_10_1016_j_euf_2022_11_016 crossref_primary_10_1016_S1761_3310_22_47076_9 crossref_primary_10_1038_s41585_022_00613_1 crossref_primary_10_1007_s00345_019_02768_w crossref_primary_10_17650_1726_9776_2021_17_2_104_111 crossref_primary_10_1039_c8pp00409a crossref_primary_10_1186_s12894_023_01279_6 crossref_primary_10_1007_s00345_017_2139_9 crossref_primary_10_3389_fsurg_2021_790738 crossref_primary_10_3389_fonc_2021_699210 |
Cites_doi | 10.1136/bmj.d5928 10.1089/end.2010.0276 10.1111/iju.12554 10.1007/s12094-012-0800-8 10.1186/1471-2490-14-97 10.1016/j.urology.2008.06.026 10.1111/bju.12341 10.1159/000209368 10.1097/MOU.0000000000000148 10.5489/cuaj.2408 10.1111/j.1464-410X.2012.11068.x 10.1016/j.eururo.2004.01.021 10.1016/j.eururo.2015.06.044 10.1111/j.1464-410X.2012.11199.x 10.1111/j.1464-410X.2011.10363.x 10.1016/j.eururo.2013.12.007 10.1007/s11255-013-0514-z 10.1016/j.urolonc.2013.01.001 10.1016/j.ejca.2009.06.016 10.1016/j.eururo.2014.09.027 10.1089/end.1999.13.289 10.1089/end.2015.0044 10.1089/end.2008.0251 10.1007/s00345-012-0948-4 10.7314/APJCP.2015.16.14.5907 10.1111/j.1464-410X.2012.11066.x 10.1111/j.1464-410X.2012.10960.x 10.1016/j.juro.2010.02.005 10.1016/j.urology.2005.12.034 10.3322/caac.21332 10.1016/j.eururo.2012.10.020 10.1016/j.juro.2012.12.006 10.1016/j.ejso.2014.06.007 10.1016/j.juro.2011.09.150 10.1016/j.urology.2012.12.059 10.1016/j.urolonc.2015.03.006 10.1111/j.1464-410X.2007.06993.x 10.1136/bmj.b2535 10.1038/nrurol.2015.24 10.1111/j.1464-410X.2008.07535.x 10.1016/j.juro.2015.11.036 |
ContentType | Journal Article |
Copyright | 2016 European Association of Urology European Association of Urology Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2016 European Association of Urology – notice: European Association of Urology – notice: Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.eururo.2016.07.014 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1873-7560 |
EndPage | 1068 |
ExternalDocumentID | 27477528 10_1016_j_eururo_2016_07_014 S0302283816304195 1_s2_0_S0302283816304195 |
Genre | Systematic Review Journal Article Comparative Study |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 0~B 1B1 1P~ 1~. 1~5 29G 30W 34G 39C 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 8UI AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYIC AAYWO ABBQC ABBTS ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ABWCG ABWVN ABXDB ACDAQ ACIEU ACQXL ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEVXI AEYAO AFJKZ AFPUW AFRHN AFSIO AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CAG COF CS3 CYUIP DU5 E0A EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FB. FDB FEDTE FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O1H O9- OAUVE OK. OW. OZT P-8 P-9 P2P PC. Q38 RKO ROL RPZ SCC SDF SDG SEL SES SEW SPCBC SSH SSZ T5K UDS UJ6 UV1 X7M Z5R ZGI ZXP ~G- AACTN AFCTW AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU AZPMC EFLBG LCYCR ZA5 AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 ACLOT ~HD |
ID | FETCH-LOGICAL-c536t-570d2e58c732883ffc1f05771f1a5fa1bd2103df2748d90f540d4ce68446c46c3 |
IEDL.DBID | AIKHN |
ISSN | 0302-2838 1873-7560 |
IngestDate | Sun Sep 28 06:31:08 EDT 2025 Mon Jul 21 06:07:45 EDT 2025 Tue Jul 01 02:55:24 EDT 2025 Thu Apr 24 23:02:12 EDT 2025 Fri Feb 23 02:16:44 EST 2024 Tue Feb 25 20:12:31 EST 2025 Tue Aug 26 17:11:57 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Ureteral neoplasms Recurrence Renal pelvis Ureter Ureteroscopy Urinary tract Urothelial carcinoma Survival |
Language | English |
License | Copyright © 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c536t-570d2e58c732883ffc1f05771f1a5fa1bd2103df2748d90f540d4ce68446c46c3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 ObjectType-Review-3 content type line 23 ObjectType-Undefined-4 |
PMID | 27477528 |
PQID | 1826740006 |
PQPubID | 23479 |
PageCount | 17 |
ParticipantIDs | proquest_miscellaneous_1826740006 pubmed_primary_27477528 crossref_citationtrail_10_1016_j_eururo_2016_07_014 crossref_primary_10_1016_j_eururo_2016_07_014 elsevier_sciencedirect_doi_10_1016_j_eururo_2016_07_014 elsevier_clinicalkeyesjournals_1_s2_0_S0302283816304195 elsevier_clinicalkey_doi_10_1016_j_eururo_2016_07_014 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-12-01 |
PublicationDateYYYYMMDD | 2016-12-01 |
PublicationDate_xml | – month: 12 year: 2016 text: 2016-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | European urology |
PublicationTitleAlternate | Eur Urol |
PublicationYear | 2016 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Cutress, Stewart, Tudor (bib0285) 2013; 189 Rastinehad, Ost, Vanderbrink (bib0385) 2009; 73 Hoffman, Yossepowitch, Erlich (bib0270) 2014; 14 Lughezzani, Jeldres, Isbarn (bib0330) 2009; 45 Siegel, Miller, Jemal (bib0210) 2016; 66 Colin, Ouzzane, Pignot (bib0295) 2012; 110 Lee, Jabbour, Marshall (bib0355) 1999; 13 Bin, Roy, Ghiraldi (bib0300) 2012; 110 Treuthardt, Danuser, Studer (bib0380) 2004; 46 Simhan, Smaldone, Egleston (bib0255) 2014; 114 Bing-bing, Cheng, Han-zhong (bib0310) 2012; 14 Pak, Moskowitz, Bagley (bib0390) 2009; 23 Dalpiaz, Ehrlich, Quehenberger (bib0265) 2014; 32 Higgins, Altman, Gøtzsche (bib0360) 2011; 343 Gadzinski, Roberts, Faerber (bib0325) 2010; 183 Dragicevic, Djokic, Pekmezovic (bib0335) 2009; 82 Giannarini, Schumacher, Thalmann (bib0345) 2007; 100 Grasso, Fishman, Cohen (bib0305) 2012; 110 Rouprêt, Babjuk, Compérat (bib0215) 2015; 68 Luo, She, Xiong (bib0410) 2015; 16 Audenet, Traxer, Yates (bib0220) 2012; 109 Cutress, Stewart, Zakikhani (bib0375) 2012; 110 Silberstein, Power, Savage (bib0315) 2012; 187 Fukushima, Saito, Ishioka (bib0275) 2014; 21 Seisen, Nison, Remzi (bib0365) 2016; 195 Singla, Gayed, Bagrodia (bib0395) 2015; 33 Yakoubi, Colin, Seisen (bib0405) 2014; 40 Seisen, Colin, Rouprêt (bib0225) 2015; 12 Colin, Rouprêt, Ghoneim (bib0235) 2013; 63 Moher, Liberati, Tetzlaff, Altman (bib0245) 2009; 339 Fajkovic, Klatte, Nagele (bib0280) 2013; 31 Lucas, Svatek, Olgin (bib0340) 2008; 102 Haddad, Cloutier, Cornu (bib0370) 2015; 29 Raymundo, Lipkin, Bañez (bib0320) 2011; 25 Bagrodia, Kuehhas, Gayed (bib0290) 2013; 81 Pedrosa, Masterson, Rice (bib0250) 2015; 9 Rouprêt, Hupertan, Traxer (bib0350) 2006; 67 Lucca, Klatte, Rouprêt, Shariat (bib0400) 2015; 25 Hung, Yang, Luo (bib0260) 2014; 46 Capitanio, Terrone, Antonelli (bib0230) 2015; 67 Rouprêt, Colin, Yates (bib0240) 2014; 66 Simhan (10.1016/j.eururo.2016.07.014_bib0255) 2014; 114 Cutress (10.1016/j.eururo.2016.07.014_bib0375) 2012; 110 Singla (10.1016/j.eururo.2016.07.014_bib0395) 2015; 33 Seisen (10.1016/j.eururo.2016.07.014_bib0365) 2016; 195 Treuthardt (10.1016/j.eururo.2016.07.014_bib0380) 2004; 46 Dalpiaz (10.1016/j.eururo.2016.07.014_bib0265) 2014; 32 Fajkovic (10.1016/j.eururo.2016.07.014_bib0280) 2013; 31 Dragicevic (10.1016/j.eururo.2016.07.014_bib0335) 2009; 82 Pak (10.1016/j.eururo.2016.07.014_bib0390) 2009; 23 Lucas (10.1016/j.eururo.2016.07.014_bib0340) 2008; 102 Luo (10.1016/j.eururo.2016.07.014_bib0410) 2015; 16 Rastinehad (10.1016/j.eururo.2016.07.014_bib0385) 2009; 73 Bin (10.1016/j.eururo.2016.07.014_bib0300) 2012; 110 Rouprêt (10.1016/j.eururo.2016.07.014_bib0215) 2015; 68 Yakoubi (10.1016/j.eururo.2016.07.014_bib0405) 2014; 40 Siegel (10.1016/j.eururo.2016.07.014_bib0210) 2016; 66 Giannarini (10.1016/j.eururo.2016.07.014_bib0345) 2007; 100 Hung (10.1016/j.eururo.2016.07.014_bib0260) 2014; 46 Colin (10.1016/j.eururo.2016.07.014_bib0235) 2013; 63 Seisen (10.1016/j.eururo.2016.07.014_bib0225) 2015; 12 Lucca (10.1016/j.eururo.2016.07.014_bib0400) 2015; 25 Raymundo (10.1016/j.eururo.2016.07.014_bib0320) 2011; 25 Rouprêt (10.1016/j.eururo.2016.07.014_bib0350) 2006; 67 Silberstein (10.1016/j.eururo.2016.07.014_bib0315) 2012; 187 Lee (10.1016/j.eururo.2016.07.014_bib0355) 1999; 13 Capitanio (10.1016/j.eururo.2016.07.014_bib0230) 2015; 67 Hoffman (10.1016/j.eururo.2016.07.014_bib0270) 2014; 14 Lughezzani (10.1016/j.eururo.2016.07.014_bib0330) 2009; 45 Haddad (10.1016/j.eururo.2016.07.014_bib0370) 2015; 29 Moher (10.1016/j.eururo.2016.07.014_bib0245) 2009; 339 Bagrodia (10.1016/j.eururo.2016.07.014_bib0290) 2013; 81 Pedrosa (10.1016/j.eururo.2016.07.014_bib0250) 2015; 9 Audenet (10.1016/j.eururo.2016.07.014_bib0220) 2012; 109 Grasso (10.1016/j.eururo.2016.07.014_bib0305) 2012; 110 Bing-bing (10.1016/j.eururo.2016.07.014_bib0310) 2012; 14 Colin (10.1016/j.eururo.2016.07.014_bib0295) 2012; 110 Cutress (10.1016/j.eururo.2016.07.014_bib0285) 2013; 189 Rouprêt (10.1016/j.eururo.2016.07.014_bib0240) 2014; 66 Gadzinski (10.1016/j.eururo.2016.07.014_bib0325) 2010; 183 Fukushima (10.1016/j.eururo.2016.07.014_bib0275) 2014; 21 Higgins (10.1016/j.eururo.2016.07.014_bib0360) 2011; 343 28505892 - J Urol. 2017 Jun;197(6):1437-1438. doi: 10.1016/j.juro.2017.03.046. 27687822 - Eur Urol. 2017 Apr;71(4):e109-e110. doi: 10.1016/j.eururo.2016.09.028. 27666997 - Eur Urol. 2017 Apr;71(4):e111-e112. doi: 10.1016/j.eururo.2016.09.027. |
References_xml | – volume: 12 start-page: 155 year: 2015 end-page: 166 ident: bib0225 article-title: Risk-adapted strategy for the kidney-sparing management of upper tract tumours publication-title: Nat Rev Urol – volume: 31 start-page: 37 year: 2013 end-page: 44 ident: bib0280 article-title: Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience publication-title: World J Urol – volume: 100 start-page: 264 year: 2007 end-page: 268 ident: bib0345 article-title: Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised? publication-title: BJU Int – volume: 66 start-page: 7 year: 2016 end-page: 30 ident: bib0210 article-title: Cancer statistics, 2016 publication-title: CA Cancer J Clin – volume: 73 start-page: 27 year: 2009 end-page: 31 ident: bib0385 article-title: A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy? publication-title: Urology – volume: 23 start-page: 341 year: 2009 end-page: 346 ident: bib0390 article-title: What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival publication-title: J Endourol – volume: 339 start-page: b2535 year: 2009 ident: bib0245 article-title: PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement publication-title: BMJ – volume: 82 start-page: 335 year: 2009 end-page: 340 ident: bib0335 article-title: Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma publication-title: Urol Int – volume: 81 start-page: 972 year: 2013 end-page: 977 ident: bib0290 article-title: Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma publication-title: Urology – volume: 67 start-page: 1181 year: 2006 end-page: 1187 ident: bib0350 article-title: Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma publication-title: Urology – volume: 109 start-page: 608 year: 2012 end-page: 613 ident: bib0220 article-title: Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract publication-title: BJU Int – volume: 14 start-page: 97 year: 2014 ident: bib0270 article-title: Oncologic results of nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy - a case control study publication-title: BMC Urol – volume: 46 start-page: 442 year: 2004 end-page: 443 ident: bib0380 article-title: Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis publication-title: Eur Urol – volume: 189 start-page: 2054 year: 2013 end-page: 2060 ident: bib0285 article-title: Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience publication-title: J Urol – volume: 46 start-page: 921 year: 2014 end-page: 926 ident: bib0260 article-title: Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer publication-title: Int Urol Nephrol – volume: 29 start-page: 969 year: 2015 end-page: 973 ident: bib0370 article-title: Immediate nephroureterectomy or after attempting conservative treatment, on elective indications, for upper urinary tract urothelial carcinoma: comparison of the pathology reports on a retrospective monocentric study publication-title: J Endourol – volume: 25 start-page: 377 year: 2011 end-page: 384 ident: bib0320 article-title: Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma publication-title: J Endourol – volume: 21 start-page: 1098 year: 2014 end-page: 1104 ident: bib0275 article-title: Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter study publication-title: Int J Urol – volume: 110 start-page: E514 year: 2012 end-page: E519 ident: bib0300 article-title: Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours publication-title: BJU Int – volume: 110 start-page: 614 year: 2012 end-page: 628 ident: bib0375 article-title: Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review publication-title: BJU Int – volume: 32 start-page: 34.e1 year: 2014 end-page: 34.e8 ident: bib0265 article-title: Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter publication-title: Urol Oncol – volume: 68 start-page: 868 year: 2015 end-page: 879 ident: bib0215 article-title: European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update publication-title: Eur Urol – volume: 110 start-page: 1618 year: 2012 end-page: 1626 ident: bib0305 article-title: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients publication-title: BJU Int – volume: 33 start-page: 268.e1 year: 2015 end-page: 268.e7 ident: bib0395 article-title: Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma publication-title: Urol Oncol – volume: 195 start-page: 1354 year: 2016 end-page: 1361 ident: bib0365 article-title: Oncologic outcomes of kidney-sparing surgery versus kidney sparing surgery for the elective treatment of clinically organ confined upper tract urothelial carcinoma of the distal ureter publication-title: J Urol – volume: 102 start-page: 172 year: 2008 end-page: 176 ident: bib0340 article-title: Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery publication-title: BJU Int – volume: 16 start-page: 5907 year: 2015 end-page: 5912 ident: bib0410 article-title: Kidney-sparing management versus nephroureterectomy for upper tract urothelial carcinoma: a systematic review and meta-analysis publication-title: Asian Pac J Cancer Prev – volume: 66 start-page: 181 year: 2014 end-page: 183 ident: bib0240 article-title: A new proposal to risk stratify urothelial carcinomas of the upper urinary tract (UTUCs) in a predefinitive treatment setting: low-risk versus high-risk UTUCs publication-title: Eur Urol – volume: 40 start-page: 1629 year: 2014 end-page: 1634 ident: bib0405 article-title: Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies publication-title: Eur J Surg Oncol – volume: 14 start-page: 312 year: 2012 end-page: 316 ident: bib0310 article-title: Correlation between surgical modality and clinicopathologic characteristics for ureteral transitional cell carcinoma publication-title: Clin Transl Oncol – volume: 9 start-page: E187 year: 2015 end-page: E192 ident: bib0250 article-title: Oncologic outcomes and prognostic impact of urothelial recurrences in patients undergoing segmental and total ureterectomy for upper tract urothelial carcinoma publication-title: Can Urol Assoc J – volume: 114 start-page: 216 year: 2014 end-page: 220 ident: bib0255 article-title: Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma publication-title: BJU Int – volume: 187 start-page: 429 year: 2012 end-page: 434 ident: bib0315 article-title: Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma publication-title: J Urol – volume: 67 start-page: 683 year: 2015 end-page: 689 ident: bib0230 article-title: Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with T1a-T1b renal mass and normal preoperative renal function publication-title: Eur Urol – volume: 183 start-page: 2148 year: 2010 end-page: 2153 ident: bib0325 article-title: Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma publication-title: J Urol – volume: 343 start-page: d5928 year: 2011 ident: bib0360 article-title: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials publication-title: BMJ – volume: 45 start-page: 3291 year: 2009 end-page: 3297 ident: bib0330 article-title: Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients publication-title: Eur J Cancer – volume: 25 start-page: 100 year: 2015 end-page: 104 ident: bib0400 article-title: Kidney-sparing surgery for upper tract urothelial cancer publication-title: Curr Opin Urol – volume: 63 start-page: 405 year: 2013 end-page: 406 ident: bib0235 article-title: Conservative management of upper tract urothelial carcinoma in France: a 2004-2011 national practice report publication-title: Eur Urol – volume: 13 start-page: 289 year: 1999 end-page: 294 ident: bib0355 article-title: 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes publication-title: J Endourol – volume: 110 start-page: 1134 year: 2012 end-page: 1141 ident: bib0295 article-title: Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study publication-title: BJU Int – volume: 343 start-page: d5928 year: 2011 ident: 10.1016/j.eururo.2016.07.014_bib0360 article-title: The Cochrane Collaboration's tool for assessing risk of bias in randomised trials publication-title: BMJ doi: 10.1136/bmj.d5928 – volume: 25 start-page: 377 year: 2011 ident: 10.1016/j.eururo.2016.07.014_bib0320 article-title: Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma publication-title: J Endourol doi: 10.1089/end.2010.0276 – volume: 21 start-page: 1098 year: 2014 ident: 10.1016/j.eururo.2016.07.014_bib0275 article-title: Equivalent survival and improved preservation of renal function after distal ureterectomy compared with nephroureterectomy in patients with urothelial carcinoma of the distal ureter: a propensity score-matched multicenter study publication-title: Int J Urol doi: 10.1111/iju.12554 – volume: 14 start-page: 312 year: 2012 ident: 10.1016/j.eururo.2016.07.014_bib0310 article-title: Correlation between surgical modality and clinicopathologic characteristics for ureteral transitional cell carcinoma publication-title: Clin Transl Oncol doi: 10.1007/s12094-012-0800-8 – volume: 14 start-page: 97 year: 2014 ident: 10.1016/j.eururo.2016.07.014_bib0270 article-title: Oncologic results of nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy - a case control study publication-title: BMC Urol doi: 10.1186/1471-2490-14-97 – volume: 73 start-page: 27 year: 2009 ident: 10.1016/j.eururo.2016.07.014_bib0385 article-title: A 20-year experience with percutaneous resection of upper tract transitional carcinoma: is there an oncologic benefit with adjuvant bacillus Calmette Guérin therapy? publication-title: Urology doi: 10.1016/j.urology.2008.06.026 – volume: 114 start-page: 216 year: 2014 ident: 10.1016/j.eururo.2016.07.014_bib0255 article-title: Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma publication-title: BJU Int doi: 10.1111/bju.12341 – volume: 82 start-page: 335 year: 2009 ident: 10.1016/j.eururo.2016.07.014_bib0335 article-title: Comparison of open nephroureterectomy and open conservative management of upper urinary tract transitional cell carcinoma publication-title: Urol Int doi: 10.1159/000209368 – volume: 25 start-page: 100 year: 2015 ident: 10.1016/j.eururo.2016.07.014_bib0400 article-title: Kidney-sparing surgery for upper tract urothelial cancer publication-title: Curr Opin Urol doi: 10.1097/MOU.0000000000000148 – volume: 9 start-page: E187 year: 2015 ident: 10.1016/j.eururo.2016.07.014_bib0250 article-title: Oncologic outcomes and prognostic impact of urothelial recurrences in patients undergoing segmental and total ureterectomy for upper tract urothelial carcinoma publication-title: Can Urol Assoc J doi: 10.5489/cuaj.2408 – volume: 110 start-page: 614 year: 2012 ident: 10.1016/j.eururo.2016.07.014_bib0375 article-title: Ureteroscopic and percutaneous management of upper tract urothelial carcinoma (UTUC): systematic review publication-title: BJU Int doi: 10.1111/j.1464-410X.2012.11068.x – volume: 46 start-page: 442 year: 2004 ident: 10.1016/j.eururo.2016.07.014_bib0380 article-title: Tumor seeding following percutaneous antegrade treatment of transitional cell carcinoma in the renal pelvis publication-title: Eur Urol doi: 10.1016/j.eururo.2004.01.021 – volume: 68 start-page: 868 year: 2015 ident: 10.1016/j.eururo.2016.07.014_bib0215 article-title: European Association of Urology guidelines on upper urinary tract urothelial cell carcinoma: 2015 update publication-title: Eur Urol doi: 10.1016/j.eururo.2015.06.044 – volume: 110 start-page: E514 year: 2012 ident: 10.1016/j.eururo.2016.07.014_bib0300 article-title: Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours publication-title: BJU Int doi: 10.1111/j.1464-410X.2012.11199.x – volume: 109 start-page: 608 year: 2012 ident: 10.1016/j.eururo.2016.07.014_bib0220 article-title: Potential role of photodynamic techniques combined with new generation flexible ureterorenoscopes and molecular markers for the management of urothelial carcinoma of the upper urinary tract publication-title: BJU Int doi: 10.1111/j.1464-410X.2011.10363.x – volume: 66 start-page: 181 year: 2014 ident: 10.1016/j.eururo.2016.07.014_bib0240 article-title: A new proposal to risk stratify urothelial carcinomas of the upper urinary tract (UTUCs) in a predefinitive treatment setting: low-risk versus high-risk UTUCs publication-title: Eur Urol doi: 10.1016/j.eururo.2013.12.007 – volume: 46 start-page: 921 year: 2014 ident: 10.1016/j.eururo.2016.07.014_bib0260 article-title: Segmental ureterectomy does not compromise the oncologic outcome compared with nephroureterectomy for pure ureter cancer publication-title: Int Urol Nephrol doi: 10.1007/s11255-013-0514-z – volume: 32 start-page: 34.e1 year: 2014 ident: 10.1016/j.eururo.2016.07.014_bib0265 article-title: Distal ureterectomy is a safe surgical option in patients with urothelial carcinoma of the distal ureter publication-title: Urol Oncol doi: 10.1016/j.urolonc.2013.01.001 – volume: 45 start-page: 3291 year: 2009 ident: 10.1016/j.eururo.2016.07.014_bib0330 article-title: Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients publication-title: Eur J Cancer doi: 10.1016/j.ejca.2009.06.016 – volume: 67 start-page: 683 year: 2015 ident: 10.1016/j.eururo.2016.07.014_bib0230 article-title: Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with T1a-T1b renal mass and normal preoperative renal function publication-title: Eur Urol doi: 10.1016/j.eururo.2014.09.027 – volume: 13 start-page: 289 year: 1999 ident: 10.1016/j.eururo.2016.07.014_bib0355 article-title: 13-year survival comparison of percutaneous and open nephroureterectomy approaches for management of transitional cell carcinoma of renal collecting system: equivalent outcomes publication-title: J Endourol doi: 10.1089/end.1999.13.289 – volume: 29 start-page: 969 year: 2015 ident: 10.1016/j.eururo.2016.07.014_bib0370 article-title: Immediate nephroureterectomy or after attempting conservative treatment, on elective indications, for upper urinary tract urothelial carcinoma: comparison of the pathology reports on a retrospective monocentric study publication-title: J Endourol doi: 10.1089/end.2015.0044 – volume: 23 start-page: 341 year: 2009 ident: 10.1016/j.eururo.2016.07.014_bib0390 article-title: What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? An objective analysis of cost and survival publication-title: J Endourol doi: 10.1089/end.2008.0251 – volume: 31 start-page: 37 year: 2013 ident: 10.1016/j.eururo.2016.07.014_bib0280 article-title: Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experience publication-title: World J Urol doi: 10.1007/s00345-012-0948-4 – volume: 16 start-page: 5907 year: 2015 ident: 10.1016/j.eururo.2016.07.014_bib0410 article-title: Kidney-sparing management versus nephroureterectomy for upper tract urothelial carcinoma: a systematic review and meta-analysis publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2015.16.14.5907 – volume: 110 start-page: 1618 year: 2012 ident: 10.1016/j.eururo.2016.07.014_bib0305 article-title: Ureteroscopic and extirpative treatment of upper urinary tract urothelial carcinoma: a 15-year comprehensive review of 160 consecutive patients publication-title: BJU Int doi: 10.1111/j.1464-410X.2012.11066.x – volume: 110 start-page: 1134 year: 2012 ident: 10.1016/j.eururo.2016.07.014_bib0295 article-title: Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study publication-title: BJU Int doi: 10.1111/j.1464-410X.2012.10960.x – volume: 183 start-page: 2148 year: 2010 ident: 10.1016/j.eururo.2016.07.014_bib0325 article-title: Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma publication-title: J Urol doi: 10.1016/j.juro.2010.02.005 – volume: 67 start-page: 1181 year: 2006 ident: 10.1016/j.eururo.2016.07.014_bib0350 article-title: Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma publication-title: Urology doi: 10.1016/j.urology.2005.12.034 – volume: 66 start-page: 7 year: 2016 ident: 10.1016/j.eururo.2016.07.014_bib0210 article-title: Cancer statistics, 2016 publication-title: CA Cancer J Clin doi: 10.3322/caac.21332 – volume: 63 start-page: 405 year: 2013 ident: 10.1016/j.eururo.2016.07.014_bib0235 article-title: Conservative management of upper tract urothelial carcinoma in France: a 2004-2011 national practice report publication-title: Eur Urol doi: 10.1016/j.eururo.2012.10.020 – volume: 189 start-page: 2054 year: 2013 ident: 10.1016/j.eururo.2016.07.014_bib0285 article-title: Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience publication-title: J Urol doi: 10.1016/j.juro.2012.12.006 – volume: 40 start-page: 1629 year: 2014 ident: 10.1016/j.eururo.2016.07.014_bib0405 article-title: Radical nephroureterectomy versus endoscopic procedures for the treatment of localised upper tract urothelial carcinoma: a meta-analysis and a systematic review of current evidence from comparative studies publication-title: Eur J Surg Oncol doi: 10.1016/j.ejso.2014.06.007 – volume: 187 start-page: 429 year: 2012 ident: 10.1016/j.eururo.2016.07.014_bib0315 article-title: Renal function and oncologic outcomes of parenchymal sparing ureteral resection versus radical nephroureterectomy for upper tract urothelial carcinoma publication-title: J Urol doi: 10.1016/j.juro.2011.09.150 – volume: 81 start-page: 972 year: 2013 ident: 10.1016/j.eururo.2016.07.014_bib0290 article-title: Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma publication-title: Urology doi: 10.1016/j.urology.2012.12.059 – volume: 33 start-page: 268.e1 year: 2015 ident: 10.1016/j.eururo.2016.07.014_bib0395 article-title: Multi-institutional analysis of renal function outcomes following radical nephroureterectomy and partial ureterectomy for upper tract urothelial carcinoma publication-title: Urol Oncol doi: 10.1016/j.urolonc.2015.03.006 – volume: 100 start-page: 264 year: 2007 ident: 10.1016/j.eururo.2016.07.014_bib0345 article-title: Elective management of transitional cell carcinoma of the distal ureter: can kidney-sparing surgery be advised? publication-title: BJU Int doi: 10.1111/j.1464-410X.2007.06993.x – volume: 339 start-page: b2535 year: 2009 ident: 10.1016/j.eururo.2016.07.014_bib0245 article-title: PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement publication-title: BMJ doi: 10.1136/bmj.b2535 – volume: 12 start-page: 155 year: 2015 ident: 10.1016/j.eururo.2016.07.014_bib0225 article-title: Risk-adapted strategy for the kidney-sparing management of upper tract tumours publication-title: Nat Rev Urol doi: 10.1038/nrurol.2015.24 – volume: 102 start-page: 172 year: 2008 ident: 10.1016/j.eururo.2016.07.014_bib0340 article-title: Conservative management in selected patients with upper tract urothelial carcinoma compares favourably with early radical surgery publication-title: BJU Int doi: 10.1111/j.1464-410X.2008.07535.x – volume: 195 start-page: 1354 year: 2016 ident: 10.1016/j.eururo.2016.07.014_bib0365 article-title: Oncologic outcomes of kidney-sparing surgery versus kidney sparing surgery for the elective treatment of clinically organ confined upper tract urothelial carcinoma of the distal ureter publication-title: J Urol doi: 10.1016/j.juro.2015.11.036 – reference: 28505892 - J Urol. 2017 Jun;197(6):1437-1438. doi: 10.1016/j.juro.2017.03.046. – reference: 27687822 - Eur Urol. 2017 Apr;71(4):e109-e110. doi: 10.1016/j.eururo.2016.09.028. – reference: 27666997 - Eur Urol. 2017 Apr;71(4):e111-e112. doi: 10.1016/j.eururo.2016.09.027. |
SSID | ssj0003593 |
Score | 2.6122634 |
SecondaryResourceType | review_article |
Snippet | There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for upper tract... Abstract Context There is uncertainty regarding the oncologic effectiveness of kidney-sparing surgery (KSS) compared with radical nephroureterectomy (RNU) for... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1052 |
SubjectTerms | Carcinoma, Transitional Cell - surgery Humans Kidney Kidney Neoplasms - surgery Nephroureterectomy - methods Organ Sparing Treatments Recurrence Renal pelvis Survival Ureter Ureter - surgery Ureteral neoplasms Ureteral Neoplasms - surgery Ureteroscopy Ureteroscopy - methods Urinary tract Urology Urothelial carcinoma |
Title | Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0302283816304195 https://www.clinicalkey.es/playcontent/1-s2.0-S0302283816304195 https://dx.doi.org/10.1016/j.eururo.2016.07.014 https://www.ncbi.nlm.nih.gov/pubmed/27477528 https://www.proquest.com/docview/1826740006 |
Volume | 70 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELa2TkK8IH5TfkyHxGtoUttNwlupNjqmdYgu0t4sx7FRUZtUSYPUF_49_i3umqQCwTSElJdGcZ3kLp8_23ffMfbGRBmy6Fh6QnDriZGMvdjnmRc7p3noD43QtN5xMRtNE_HxWl4fsEmXC0NhlS32N5i-Q-v2zKB9m4P1YjGYo3uSdkuEjMIXQSwP2dEQR_uox47GZ-fT2R6Qeau9y3eZyDzqMuh2YV62LuuSsgCDRsUzEDeNUDcx0N1IdHqf3WspJIybu3zADmz-kN25aDfJH7Efl7lpIA0u6w0-mK2gcHC-yHK79SoqO5h_gXmTDw20YFZX8FnvNmxgZtdUuaekKBla0F9tAWktJOu1LeGKUqogKSlra4mOCxOqRJQXK_0OxjDfi0JDs-MA6RbwSjgZJzArcm9VV3jDcJZ_0xQ0D--XBHsl_gu-9RI-1CS5RWH48EnndvmYJacnV5Op19Zr8Izko40nQz8bWhkZEgCKuHMmcEgHw8AFWjodpBnOL3nmcCKMHuI7JIuZMHYU4ZTU4MGfsF5e5PYZAycNz9I00HGqhUN3kllqBIn_hXHsQt1nvLORMq2YOdXUWKouau2raiyryLLKDxVats-8fat1I-Zxy_WyM7_qElURWhWONre0C__WzlYtPlQqUNVQ-eoPH_615W-fwT_0-brzT4UIQds-aKqixr5wBhkK4iV99rRx3P3T05pEKIfR8__u9wW7S7-aCJ-XrLcpa_sKedomPWaHb78Hx-3X-BPL4j_e |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nj9MwELWWrgRcEN-Uz0HiGjWp7SbhVqpdWrrtItpKe7Mcx0ZFbVolDVJ_IX-LmSapQLBahJRTE9dJZvL8bM-8YeydiVJk0bH0hODWEz0Ze7HPUy92TvPQ7xqhab1jMu0NF-LTlbw6YYMmF4bCKmvsrzD9gNb1L536bXa2y2Vnhu5J2i0RMgpfBLG8xU4FFbVusdP-aDycHgGZ19q7_JCJzKMmg-4Q5mXLvMwpCzCoVDwDcd0IdR0DPYxE5_fZvZpCQr-6ywfsxGYP2e1JvUn-iP24zEwFaXBZ7vDBbAEbB-Nlmtm9V1DZwewrzKp8aKAFs7KAL_qwYQNTu6XKPTlFydCC_noPSGthsd3aHOaUUgWLnLK2Vui4MKBKRNlmrd9DH2ZHUWiodhwg2QNeCWf9BUw3mbcuC7xhGGXfNQXNw4cVwV6O_4JvPYePJUluURg-fNaZXT1mi_Oz-WDo1fUaPCN5b-fJ0E-7VkaGBIAi7pwJHNLBMHCBlk4HSYrzS546nAijh_gOyWIqjO1FOCU1ePAnrJVtMvuMgZOGp0kS6DjRwqE7yTQxgsT_wjh2oW4z3thImVrMnGpqrFQTtfZNVZZVZFnlhwot22besdW2EvO44XrZmF81iaoIrQpHmxvahX9rZ4saHwoVqKKrfPWHD__a8rfP4B_6fNv4p0KEoG0fNNWmxL5wBhkK4iVt9rRy3OPT05pEKLvR8__u9w27M5xPLtTFaDp-we7SmSra5yVr7fLSvkLOtkte19_kT06AQcQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Oncologic+Outcomes+of+Kidney-sparing+Surgery+Versus+Radical+Nephroureterectomy+for+Upper+Tract+Urothelial+Carcinoma%3A+A+Systematic+Review+by+the+EAU+Non-muscle+Invasive+Bladder+Cancer+Guidelines+Panel&rft.jtitle=European+urology&rft.au=Seisen%2C+Thomas&rft.au=Peyronnet%2C+Benoit&rft.au=Dominguez-Escrig%2C+Jose+Luis&rft.au=Bruins%2C+Harman+M.&rft.date=2016-12-01&rft.pub=Elsevier+B.V&rft.issn=0302-2838&rft.volume=70&rft.issue=6&rft.spage=1052&rft.epage=1068&rft_id=info:doi/10.1016%2Fj.eururo.2016.07.014&rft.externalDocID=S0302283816304195 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F03022838%2FS0302283816X00103%2Fcov150h.gif |